AVIR icon

Atea Pharmaceuticals
AVIR

Overview Fund Trends Analyst Outlook Journalist POV

69 hedge funds and large institutions have $2.07B invested in Atea Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$269M
2
+$260M
3
+$235M
4
RCM
RA Capital Management
Massachusetts
+$224M
5
PA
Perceptive Advisors
New York
+$130M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.37M
27
$5.22M
28
$4.64M
29
$4.45M
30
$3.61M
31
$3.13M
32
$2.92M
33
$2.22M
34
$1.88M
35
$1.78M
36
$1.75M
37
$1.63M
38
$1.61M
39
$1.54M
40
$1.39M
41
$1.38M
42
$1.25M
43
$1.19M
44
$916K
45
$864K
46
$840K
47
$706K
48
$593K
49
$531K
50
$523K
1
2
3